Home FOR AUTHORS Bratislava Medical Journal 2018 Bratislava Medical Journal Vol.119, No.12, p.747–751, 2018

Journal info


 


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.564

 

Aims and Scope
Editorial Info
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.119, No.12, p.747–751, 2018

Title: TP53 rs1042522 and rs8064946 variants in myocardial infarction
Author: A. Hakobjanyan, A. Stahelova, F. Mrazek, J. Petrkova, Z. Navratilova, M. Petrek

Abstract: OBJECTIVE: This study investigated the hypothesis that the single nucleotide polymorphisms (SNPs) of TP53 gene are related to a risk of myocardial infarction.
METHODS: The coding SNP at codon 72 (rs1042522) and non-coding rs8064946 SNP were genotyped by polymerase chain reaction with sequence specific primers in 205 Czech patients with myocardial infarction and 148 Czech control subjects.
RESULTS: The distribution of both SNPs was in agreement with the Hardy–Weinberg equilibrium and was similar to other European populations. Our power analysis showed 96 % of probability to detect an odd ratio equal to 2. Neither rs1042522 nor rs8064946 were associated with the risk of myocardial infarction. The haplotypes combined of rs1042522 and rs8064946 were not associated with myocardial infarction in the present study.
CONCLUSION: The TP53 SNPs are not strongly associated with genetic predisposition to myocardial infarction (Tab. 3, Fig. 3, Ref. 23).

Keywords: myocardial infarction, tumor suppressor protein p53, genes, polymorphism, single nucleotide, polymerase chain reaction
Published online: 17-Dec-2018
Year: 2018, Volume: 119, Issue: 12 Page From: 747, Page To: 751
doi:10.4149/BLL_2018_136


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.